Centaur Pharma to launch WOXHeal, diabetic foot ulcer drug
It is a topical solution that will cost Rs 1850 for a week’s treatment, and can reportedly help prevent amputation
Sign in / Join
Sign in
Recover your password.
A password will be e-mailed to you.
Home » DCGI approval
Browsing Tag
DCGI approval
Zenara Pharma, a Biophore subsidiary, gets DCGI nod for favipiravir tablets
The company informed that these tablets, to be marketed under brand name Favizen, will be manufactured with in-house API
Mylan receives DCGI approval in India for TB drug, Pretomanid
Pretomanid is only the third new anti-tuberculosis (TB) drug developed specifically for drug-resistant forms of the disease to be…
Biocon presents key Insights into clinical study that enabled DCGI approval of Itolizumab
A multi-centric, open label, two-arm randomized pivotal clinical trial was conducted in 30 eligible patients at four hospitals…
